1 Min Read
March 6 (Reuters) - Mabvax Therapeutics Holdings Inc :
* MABVAX THERAPEUTICS REGAINS COMPLIANCE WITH NASDAQ’S $1.00 MINIMUM BID PRICE MAINTENANCE REQUIREMENT Source text for Eikon: Further company coverage: